Program Agenda

Monday, September 19, 2016

8:30 am – 4:00 pm

U.S. Affiliated Pacific Islands Grantees Meeting

Tuesday, September 20, 2016

8:30 am – 2:00 pm	Community Approaches To Reducing STDs Grantees Meeting
8:30 am – 5:00 pm	U.S. Affiliated Pacific Islands Grantees Meeting
8:30 am – 3:00 pm	Field Services Branch Meeting (Breakout Rooms)

9:00 am – 5:00 pm	STD 101 STD 101 is based on a workshop at the 2014 National STD Prevention Conference in Atlanta, Georgia. That workshop provided participants who had limited or no STD prevention experience a basic knowledge of STD prevention so that they could actively participate in the conference. STD 101 in a Box now provides users with materials for developing similar workshops. The downloadable materials are customizable for conferences, group discussions, and presentations. Topics include STD clinical and behavioral information, HIV and STD interrelationships, STD epidemiology, and STD prevention program information. Potential users include but are not limited to community-based organizations, public health departments, and schools of public health, health educators, primary care providers, and disease intervention specialists.
11:00 am – 5:00 pm	REGISTRATION/INFORMATION OPEN
1:00 pm – 3:30 pm	STD Surveillance Coordinators Meeting (Invitation Only by CSTE)
9:00 am–4:00 pm	Field Epi Unit (By Invitation Only)
1:00 pm – 4:00 pm	Grantee Meeting for DSTDP Enhanced Evaluation Awardees (By Invitation Only)
1:00 pm – 4:30 pm	Technology-Based HIV and STD Prevention: From Partner Services to Messaging to Structural Interventions This informational and interactive session will provide updates on the best practices for using technology to reach populations at risk with health information and for improving partner services. Current collaborations with business owners in developing structural interventions for STD and HIV prevention also will be discussed. Frank Strona and Rachel Kachur of the working group Using Technology to Advance STD/HIV Prevention Services will introduce CDC’s newly released toolkit for technology-based partner services, provide an introductory overview of the common features found on popular sex-seeking mobile apps, and update participants on other available resources and technical assistance opportunities. Dan Wohlfeiler, Director, Building Healthy Online Communities, will describe their efforts in leveraging partnerships with business owners to develop structural interventions for increasing awareness about STD/HIV prevention. The partnerships synthesize health department activities and messaging to maximize impact and cross-jurisdiction collaboration, and these interventions help users of dating and hook-up sites make informed choices. Time permitting, participants will be able to network with colleagues, learn how different programs use technology for partner services, and explore cross-jurisdictional opportunities.
3:00 pm – 4:00 pm	Syphilis Prevention in the United States: Where do we go from here? An overview of the 2016 Syphilis Summit and discussion about next steps in national syphilis prevention.
3:30 pm -5:30 pm	Sexually Transmitted Diseases Editorial Board Meeting (By Invitation Only)

11:00 am – 5:00 pm      Registration/ Information Open

5:00 pm – 6:20 pm        OPENING PLENARY / The Ward Cates Memorial Lecture

PrEPortunity for STD Control
Sheena McCormack, MBBS, MSc, FRCP, Dip Ven bio
University College London, Chelsea & Westminster Hospital
London, England, United Kingdom

6:30 pm – 8:30 pm          Welcome Reception

7:00 am – 4:00 pm         Registration/ Information Open

7:00 am – 8:15 am         Continental Breakfast

7:00 am – 7:50 am         Clinical Case Series 1

Ocular Syphilis: A Need to Look for Cases in All Exposed Populations
Sancta St. Cyr, M.D., Ribka Berhanu, M.D. and Arlene C. Sena, MD, MPH, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC

Painless Jaundice and Transaminitis As a Presentation of Secondary Syphilis
Teresa Batteiger, MD, Department of Internal Medicine, Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, IN

8:00 am – 9:00 am         PLENARY SESSION 1

Microbiome and Local Immune Response

The Impact of Genital Infections and the Genital Microbiome on Mucosal and Systemic Immunology
Rupert Kaul, MD, PhD, FRCP(C)
University of Toronto
Toronto, Ontario, Canada

Molecular Tools for Studying Human Microbial Communities: Implications for STD research and Diagnostics
David Fredericks, MD, MS
University of Washington, 
Seattle, Washington

9:30 am – 10:30 am       MINI-PLENARY SESSIONS 1

Transforming Old Problems into New Solutions

Syphilis Control in the Post-elimination Era 
Matthew Golden, MD, MPH
University of Washington, Public Health – 
Seattle & King County, HIV/STD Program
Seattle, Washington

Gonococcal Resistance—Perspectives from 30 years of GISP
Jonathan Zenilman, MD
Johns Hopkins University School of Medicine
Baltimore, Maryland

Technology Innovations in STD Prevention and Control
Patrick Sullivan, PhD, DVM
Emory University Rollins School of Public Health
Atlanta, Georgia

MINI-PLENARY SESSION 2

Critical Contributors to STD Prevention

Using a Sexual Health Approach to Improve Patient Care and Public Health
Edward Hook, III, MD
University of Alabama School of Medicine
Birmingham, Alabama

Update on STI Vaccine Progress
Helen Rees, MD, MA, MRCGP
World Health Organization, Wits Reproductive Health and HIV Institute
Johannesburg, South Africa

The Transformation of American Healthcare: The Appreciation of Value
Otis Brawley, MD, FACP
Emory University School of Medicine, Winship Cancer Center
Atlanta, Georgia

10:45 am–12:00 pm      Concurrent Sessions 1A–E 

1A	Oral Presentation	Anogenital Warts and All: STD Vaccines, EPT, and Disseminated Gonococcal Infections
1B	Oral Presentation	Keeping Out the Bugs: Novel Strategies To Improve STI Screening
1C	Oral Presentation	Does It Fit the Bill? The Impact of the ACA on STD Programs
1D	Symposium	Syphilis: Reemerging Clinical Disease and Point-of-Care Tests
1E	Symposium	New Directions in Addressing Adolescent STD Risk

12:00 pm – 1:30 pm      Lunch Break/ Conference Partners Symposium

1:30 pm – 2:30 pm        PLENARY SESSION 2

How to Prevent STDs Without Doing STD Prevention: Policies To Address Poverty and Other Social Determinants of Health

A Social Justice Approach to STD Prevention
Mary Bassett, MD, MPH
New York City Department of Mental Health and Hygiene
New York City, New York

Poverty, Public Policy and Public Health
Sheldon Danziger, PhD
Russell Sage Foundation
New York, New York

3:00 pm – 4:15 pm        Concurrent Sessions 2A–E

2A	Oral Presentation	Analyze This! Using Data To Inform STD Prevention
2B	Oral Presentation	From PrEParation to Implementation
2C	Oral Presentation	School as a Tool for Combating STDs in Youth
2D	Symposium	STD/HIV Criminalization- and Incarceration-Related Policies: What Is the Impact on STD Prevention?
2E	Symposium	The Role of Sexual Transmission in Non-STI Pathogens

4:30 – 6:00 pm                DEBATE SESSIONS

Debate 1 
Should We Be doing EPT for MSM?  

Jonathan Mermin, MD, MPH
Centers for Disease Control & Prevention
Atlanta, Georgia

Matthew Golden, MD, MPH 
University of Washington, Public Health – Seattle & King County, 
HIV/STD Program 
Seattle, Washington

Debate 2
Is it Okay if MSM get STIs, Just Not HIV?

Myron S. Cohen, MD
University of North Carolina School of Medicine
Chapel Hill, North Carolina

Laura Bachmann, MD, MPH
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina

6:00 – 6:45                Scientific Poster Session 1/Poster Grand Rounds

7:00 am – 4:00 pm         Registration/ Information Open

7:00 am – 8:15 am         Continental Breakfast

7:00 am – 8:00 am         ASTDA Breakfast Symposium

7:00 am – 7:50 am         Clinical Case Series 2

A Perfect Storm of Noncompliance: Chlamydia Trachomatis Infection and Progressive Pelvic Inflammatory Disease in an Adolescent Patient
Zoon Wangu, MD, Suzanne C. Allen, MSN, CPNP and Christina R. Hermos, MD, MS, Division of Pediatric Infectious Diseases & Immunology, UMass Memorial Children’s Medical Center, Worcester, MA, Division of Adolescent Medicine, UMass Memorial Children’s Medical Center, Worcester, MA

Correct Diagnosis of Lymphogranuloma Venereum Makes All the Difference
Deborah Richmond, NP-C, Lawrence R Crane, MD FACP FIDSA, James B. Kent, MS, Paul Lephart, PhD, D(ABMM), Elizabeth A Secord, MD, Hossein Salimnia, Ph.D., D(ABMM) and Jonathan Allen Cohn, MD MS FACP FIDSA, Wayne State University Tolan Park Medical Building, Wayne State University, Detroit, MI, Epidemiology / HIV-Body Art-Viral Hepatitis-STD, Michigan Department of Health and Human Services, Lansing, MI, Detroit Medical Center University Laboratories, Detroit Medical Center, Detroit, MI, Children’s Hospital of Michigan, Wayne State University, Detroit, MI, Detroit Medical Center University Laboratories, Wayne State University, Detroit, MI

8:00 am – 9:00 am         PLENARY SESSION 3

Social Justice for Sexual and Racial Minorities

Justice or Just Us?
Mandy Carter
National Black Justice Coalition
Durham, North Carolina

Sexual Rights, Social Justice and Minoritized Groups
Eleanor Maticka-Tyndale, PhD
University of Windsor 
Windsor, Ontario, Canada

 

9:30 – 10:30 am             MINI-PLENARY SESSION 3

STD Prevention in the Context of Biomedical Interventions to Prevent HIV and Unintended Pregnancy

HIV Pre-Exposure Prophylaxis (PrEP) and Sexually Transmitted Infections (STI)
Demetre Daskalakis, MD, MPH
New York City Department of Health and Mental Hygiene
New York City, New York

The Nexus of LARC Use and STD Testing
Clare Coleman, BA
National Family Planning and Reproductive Health Association
Washington, DC

Preventing HIV, STI, and Unintended Pregnancy in Women At Risk: Evolving Evidence and Approach
Jeanne Marrazzo, MD, MPH
University of Alabama School of Medicine 
Birmingham, Alabama

 

MINI-PLENARY SESSION 4

Understanding Gender Identity: Neurodevelopmental Underpinnings, Gender Fluidity, and Creating Better Outcomes for Sexual Minorities

Gender Fluidity and Gender Identity Development
Aron C. Janssen, MD
New York University School of Medicine
New York City, New York

Transgender Populations: Epidemiology and Best Practices in STD Prevention and Care
Tonia Poteat, PhD, PA-C, MPH
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland

Impact of Social Policy on the Well-Being of LGB Populations
Ellen D. B. Riggle, PhD
University of Kentucky
Lexington, Kentucky

10:45 am–12:00 pm      Concurrent Sessions 3A–F

3A	Oral Presentation	Point-of-Care Tests Are Here, But Are They Useful?
3B	Oral Presentation	Making Networks Work for STD Prevention in MSM
3C	Oral Presentation	Do “Techno” for an Answer: Using Technology To Increase Data Yield
3D	Symposium	Beyond Chlamydia and Gonorrhea: The Epidemiology of Less Common Sexually Transmitted Pathogens
3E	Symposium	What Does It Mean To Be “LGBT-Friendly”? Creating Safe Inclusive Environments in Schools and Clinics
3F	Oral Presentation	Late-Breaker Presentations

12:00 pm – 1:30 pm      Lunch Break/ ASTDA Awards Luncheon

1:30 pm – 2:30 pm        PLENARY SESSION 4

Temporal Changes in Demographic and Health Systems

The Role of Burden of Disease, Cost-Effectiveness and Technical Efficiency in Improved Strategic Decision-Making 
Nicholas Kassebaum, MD
University of Washington
Seattle, Washington

America’s Changing Population and Family Structures: Emerging Challenges for STD Prevention
Steven Martin, PhD
Urban Institute
Washington, DC

3:00–4:15 pm                  Concurrent Sessions 4A–E

4A	Oral Presentation	Clinical Controversies in Women’s STD Care
4B	Oral Presentation	Helping Your Data Get More Action: What To Do About Syphilis and MSM
4C	Oral Presentation	The Love Shack and Other Tales of the City
4D	Symposium	Public Health Informatics
4E	Symposium	Innovative Models of Supporting Quality STD Care

 

4:40 – 5:40 pm                DEBATE SESSIONS

Debate 3
Are Use of Non-Microscopic Bacterial Vaginosis (BV) POC Tests Sufficient for Clinical Management of BV? 

Caroline Mitchell, MD
Harvard Medical School, Massachusetts General Hospital
Boston, Massachusetts

Jeanne Marrazzo, MD, MPH
University of Alabama School of Medicine
Birmingham, Alabama

Debate 4
Can Alcohol Taxes Impact STD Rates?  

David Jernigan, PhD
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland

William C. Miller, MD, PhD, MPH 
The Ohio State University College of Public Health
Columbus, Ohio
 

5:45 pm – 6: 30 pm        Scientific Poster Session 2/Poster Grand Rounds

6:45 pm – 9:00 pm         Networking Event 

7:00 am – 11:30 pm      Information Open

7:00 am – 8:15 am        Continental Breakfast

7:00 am – 7:50 am        Clinical Case Series 3

An Unexpected Bleed: A Case of Syphilitic Aortitis
Xuan Gao, M.D., Tina Wang, M.D., Steven Leung, M.D., Bella Mehta, M.D., Doruk Erkan, M.D., M.P.H and Barry Hartman, M.D., Department of Medicine, Mount Sinai Beth Israel, New York, NY, Department of Rheumatology, Hospital for Special Surgery, New York, NY, Department of Infectious Disease, New York-Presbyterian/Weill Cornell Medical Center, New York, NY

Cardiovascular Syphilis Requiring Aortic Valve and Arch Surgical Repair in an HIV-Infected Patient
Daniel Graciaa, MD, MPH, Marina Mosunjac, MD, Alan Pillay, PhD, Yetunde Fakile, PhD, Sherif Zaki, MD, PhD, Kimberly Workowski, MD and Russell Kempker, MD, MSc, Department of Medicine, Emory University School of Medicine, Atlanta, GA, Department of Pathology, Emory University School of Medicine, Atlanta, GA, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, Infectious Disease Pathology Branch, NCEZID, Centers for Disease Control and Prevention, Atlanta, GA, Department of Medicine, Div. of Infectious Disease, Emory University School of Medicine, Atlanta, GA, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA

8:00–9:15 am                Concurrent Sessions 5A–E

5A	Oral Presentation	Teenage Wasteland: Helping Providers Get It Right
5B	Oral Presentation	Clinic-Based Interventions: Novel, Fast, and Lean
5C	Oral Presentation	Congenital Syphilis and Other Perinatal Complications
5D	Symposium	The Vaginal Microenvironment: Impact on Risk of STI Acquisition
5E	Symposium	The Intersection of Policy, Science, and Population Health: Pulling on the Levers of Industry, Economics and Political Will for STD Prevention

9:30–10:45 am              Concurrent Sessions 6A–E

6A	Oral Presentation	Cutting Edge Clinical Care for MSM
6B	Oral Presentation	Leveraging Campaigns and Technology To Achieve Sexual Health
6C	Oral Presentation	Women’s Sexual and Reproductive Health Opportunities for Intervention
6D	Symposium	Combatting Antibiotic Resistant Bacteria/Advanced Molecular Detection and Resistant Neisseria gonorrhoeae
6E	Symposium	Assessment of STDs: Moving Beyond Counting Cases

11:15 am – 12:15 pm    Rapporteur Session

12:15 pm – 1:10 pm      CLOSING PLENARY SESSION

Collaborative Diagnosis: Addressing the Social Determinants of Health to Improve Outcomes
Sylvia Caley, JD, MBA, RN bio
Georgia State University, College of Law
Atlanta, Georgia

1:10 pm – 1:30 pm         ASTDA Talk & Poster Awards/ Closing Remarks